COUNTERPOINT: Routine Use of Autologous Stem Cell Transplantation in Multiple Myeloma

Over the last decade, it has become clear that there are many different subsets of multiple myeloma, all with different biological drivers and a variety of patient-based characteristics that influence therapeutic efficacy. 

 Oncology (Williston Park)

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.